From the Analyst's Couch | Published:

Systemic lupus erythematosus and lupus nephritis

Nature Reviews Drug Discovery volume 13, pages 173174 (2014) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis — Global Drug Forecast and Market Analysis to 2022 (GlobalData, 2013).

  2. 2.

    & Unmet medical needs in systemic lupus erythematosus. Arthritis Res. Ther. 14, S4 (2012).

Download references

Author information

Affiliations

  1. GlobalData, 40–42 Hatton Garden, London EC1N 8EB, UK.

    • Toli Koutsokeras
  2. GlobalData, 40–42 Hatton Garden, London EC1N 8EB, UK.

    • Tina Healy

Authors

  1. Search for Toli Koutsokeras in:

  2. Search for Tina Healy in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Toli Koutsokeras or Tina Healy.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd4227

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing